Scientist in Novozymes recognized as inspiring and influential
Novozymes’ Chief Scientist Geoffrey Francis named one of the 100 most inspiring people within life science industry by PharmaVOICE magazine.
Nottingham, UK (June 20, 2009). Novozymes today announced that Geoffrey Francis, Chief Scientist at Novozymes Biopharma, has been named one of the 100 most inspiring people by PharmaVOICE magazine in recognition of his influence in the life science industry. The PharmaVOICE 100 were nominated by PharmaVOICE readers who identified the individuals they believe have the greatest influence and positive impact on corporate leadership, research and development, technology, creativity, marketing, and business strategies.
“It’s a great honor to have been recognized by my peers and to be profiled alongside such an esteemed group of industry leaders,” commented Geoffrey Francis. “I'm delighted that this honor validates Novozymes Biopharma’s mission and is a real testament to the outstanding team we have here.”
Geoffrey Francis’ nomination and selection to the PharmaVOICE 100 was based on his exceptional 30-year career in the life sciences and biotechnology industries and his ability to inspire and motivate those around him. With specific expertise in drug discovery, protein expression, cell biology, animal physiology, and protein biochemistry, Geoffrey has a long and successful career in senior management and research within government, academia, and industry.
Determined to make a difference, Geoffrey used his expertise as part of the team to found the Cooperative Research Centre for Tissue Growth and Repair, Adelaide, in 1991 and held senior scientist positions at CSIRO HumanNutrition and GroPep Ltd. before joining Novozymes Biopharma in 2006. Based in Adelaide, Australia, Geoffrey currently is a key member of a worldwide team of scientists and advises on scientific and industry issues in the area of biopharmaceutical drug development.
Established five years ago by PharmaVOICE magazine, the PharmaVOICE 100 is an annual list of individuals recognized for their positive contributions to the life sciences industry. The distinguished honorees are nominated by thousands of PharmaVOICE readers. The PharmaVOICE 100 are selected based on comprehensive essays describing how individuals inspired or motivated them or affected positive changes as well as other factors, such as community and philanthropic activities.
Editor in chief and cofounder of PharmaVOICE, Taren Grom, comments: “The PharmaVOICE 100 are individuals who think outside the box, pioneer new paths to success, and inspire their colleagues in the industry; they translate industry issues into opportunities and take the time to mentor the next generation of leaders in the life sciences arena.”